Pregled po CROSBI profilu: Lana Ganoci (CROSBI Profil: 36158, MBZ: 382855, ORCID: 0000-0003-3898-4554)
Pronađeno 81 radova
-
51.Genetic polymorphisms of cytochrome P450 enzymes: CYP2C9, CYP2C19, CYP2D6, CYP3A4, and CYP3A5 in the Croatian population // Drug Metabolism and Personalized Therapy, 32 (2017), 1; 11-21 doi:10.1515/dmpt-2016-0024 (međunarodna recenzija, članak, znanstveni)
-
52.Dapsone-induced agranulocytosis-possible involvement of low-activity N -acetyltransferase 2 // Fundamental & Clinical Pharmacology, 31 (2017), 5; 580-586 doi:10.1111/fcp.12287 (međunarodna recenzija, članak, znanstveni)
-
53.Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study // Nordic journal of psychiatry, 71 (2017), 7; 513-520 doi:10.1080/08039488.2017.1340518 (međunarodna recenzija, članak, znanstveni)
-
54.Rat brain glucose transporter-2, insulin receptor and glial expression are acute targets of intracerebroventricular streptozotocin: risk factors for sporadic Alzheimer’s disease? // Journal of neural transmission, 124 (2017), 6; 695-708 doi:10.1007/s00702-017-1727-6 (međunarodna recenzija, članak, znanstveni)
-
55.CYP2D6 *6/*6 genotype and drug interactions as cause of haloperidol induced extrapyramidal symptoms // Pharmacogenomics, 17 (2016), 13; 1385-1389 doi:10.2217/pgs-2016-0069 (međunarodna recenzija, članak, znanstveni)
-
56.The Role Of Cyp2d6, Cyp3a4/5, And Abcb1 Polymorphisms In Patients Using Long-Acting Injectable Risperidone // European Association for Clinical Pharmacology and Therapeutics (EACPT) Focus Meeting 2016 : How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic – 3E Assessment and European Association for Clinical Pharmacology and Therapeutics (EACPT) Focus Meeting 2016 : How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic 3E Assessment : abstracts ; u: Clinical Therapeutics 38 (2016) 10 (S6) A1-A4, e1-e32
Opatija, Hrvatska, 2016. str. e10-e11 (poster, međunarodna recenzija, sažetak, znanstveni) -
57.Genetic variants of reduced clopidogrel absorption and platelet reactivity after standard clopidogrel therapy and serial dose tailoring in the NCT02096419 trial: a pharmacogenetic substudy // Cardiologia Croatica - 4th Dubrovnik Cardiology Highlights an ESC Update Programme in Cardiology / Miličić, Davor (ur.).
Zagreb: Hrvatsko kardiološko društvo / Croatian Cardiac Society, 2015. str. 205-205 doi:10.15836/ccar.2015.205 (poster, međunarodna recenzija, sažetak, znanstveni) -
58.The importance of transporters in prediction of drug efficacy and adverse events // 2. Hrvatski simpozij o transporterima (SOT-2)
Zagreb, Hrvatska, 2015. (pozvano predavanje, međunarodna recenzija, cjeloviti rad (in extenso), znanstveni) -
59.Pharmacogenomics in psychiatry // Pharmacogenomics - From Research to Clinic
Ljubljana: University of Ljubljana, 2015. str. 91-96 (pozvano predavanje, međunarodna recenzija, cjeloviti rad (in extenso), znanstveni) -
60.Integrating Pharmacogenomics with Pharmacovigilance // VI. hrvatski kongres humane genetike : knjiga sažetaka
Split, Hrvatska, 2015. (pozvano predavanje, domaća recenzija, cjeloviti rad (in extenso), znanstveni) -
61.Utjecaj polimorfizama CYP3A4/5 i CYP2D6 na serumske koncentracije risperidona i 9- hidroksirisperidona kod pacijenata na terapiji pripravkom risperidona s produljenim oslobađanjem // Biochemia Medica 2015 ; 25(Suppl 1):S55-S155. / Šimundić, Ana-Maria (ur.).
Zagreb: Croatian Society of Medical Biochemistry and Laboratory Medicine, 2015. (predavanje, međunarodna recenzija, sažetak, znanstveni) -
62.ABCG2 and CYP3A4 polymorphisms as a risk factors for developing adverse drug reactions in patients taking atorvastatin: a case-control study // Abstract Book of the 14th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology
Rotterdam, Nizozemska: IATDMCT, 2015. (predavanje, međunarodna recenzija, sažetak, znanstveni) -
63.ABCG2 gene polymorphisms as risk factors for atorvastatin adverse reactions: a case-control study. // Pharmacogenomics, 16 (2015), 8; 803-815 doi:10.2217/pgs.15.47. (međunarodna recenzija, članak, znanstveni)
-
64.CYP2C19*2 genotype influence in acute coronary syndrome patients undergoing serial clopidogrel dose tailoring based on platelet function testing : analysis from randomized controlled trial NCT02096419. // International journal of cardiology, 186 (2015), 282-285 doi:10.1016/j.ijcard.2015.03.171 (međunarodna recenzija, pismo, znanstveni)
-
65.Influence of CYP2D6 and ABCB1 polimorphisms on the serum steady-state concentrations of risperidone and 9-oh risperidone in patients using long-acting injectable risperidone // Book of Abstracts - 1st Croatian Congress of Clinical Pharmacy
Zagreb: Hrvatsko farmaceutsko društvo, 2014. (predavanje, međunarodna recenzija, sažetak, znanstveni) -
66.Influence of CYP2D6 and ABCB1 polymorphisms on the serum steady-state concentrations of risperidone and 9-oh risperidone in patients using long-acting injectable risperidone // Abstract book of the IATDMCT European Conference - Therapeutic Drug Monitoring
Prag: IATDMCT, 2014. str. 70-70 (predavanje, međunarodna recenzija, sažetak, znanstveni) -
67.Drug transporter and metabolic enzyme gene variants and fluvastatin adverse drug reactions in renal transplant recipients // European Journal of Human Genetics
Pariz, Francuska, 2013. str. 556-556 (poster, međunarodna recenzija, sažetak, znanstveni) -
68.Acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol: the association study of polymorphisms in DRD2, SLC6A3, and COMT genes // Abstract Book: 1st International Conference on Creative Psychopharmacotherapy ICCP 2013 Dubrovnik
Dubrovnik, Hrvatska, 2013. (poster, međunarodna recenzija, sažetak, znanstveni) -
69.Lethal toxicity following standard dose of 5-FU in patients carrying DPYD c.1905+1G>A mutation // Pharmacogenomics and Theranostics in practice
Firenca, Italija, 2013. (poster, međunarodna recenzija, sažetak, znanstveni) -
70.Farmakogenetika u kliničkoj praksi – preporuke i smjernice // Paediatria Croatica, 57 (2013), 4; 318-330 (recenziran, pregledni rad, stručni)
-
71.CYP2C9 and ABCG2 polymorphisms as risk factors for developing adverse drug reactions in renal transplant patients taking fluvastatin: a case- control study // Pharmacogenomics, 14 (2013), 12; 1419-1431 doi:10.2217/pgs.13.135 (podatak o recenziji nije dostupan, prethodno priopćenje, znanstveni)
-
72.Uloga polimorfizma prijenosnika lijekova u kliničkoj praksi ; put prema personaliziranom liječenju // Arhiv za higijenu rada i toksikologiju 64(2) / Kopjar, Nevenka (ur.).
Zagreb: Institut za medicinska istraživanja i medicinu rada, 2013. str. 342-342 (pozvano predavanje, međunarodna recenzija, cjeloviti rad (in extenso), znanstveni) -
73.Osnove farmakogenomike. // Farmakogenomika i farmakovigilancija - sprječavanje nuspojava u individualizaciji terapije – upute i smjernice / Božina, Nada ; Macolić-Šarinić, Viola (ur.).
Zagreb: Medicinska naklada, 2013. str. 1-22 -
74.The association study of polymorphisms DRD2, SLC6A3 and COMT genes and achieving the symptomatic remission in male schizophrenic patients treated with olanzapine // Periodicum Biologorum / Vitale, Branko (ur.).
Zagreb: Laser Plus, 2013. str. 67-67 (poster, domaća recenzija, sažetak, znanstveni) -
75.ABCG2 gene variant and fluvastatin adverse drug reactions in renal transplant recipients // Biochemia Medica
Zagreb: Hrvatsko društvo za medicinsku biokemiju i laboratorijsku medicinu (HDMBLM), 2012. (predavanje, međunarodna recenzija, sažetak, znanstveni)
